Data Snacks
Bite-sized competitive intelligence insights aligned to your disease states of interest
Filter by Disease State
Featured Data Snack
NewBCMA-Targeted Therapy Landscape Evolution
Analysis of the rapidly evolving BCMA-targeted therapy landscape in multiple myeloma, with focus on competitive positioning, differentiation strategies, and market share projections.
Sarah Johnson, PhD • May 25, 2025
All Data Snacks
Bispecific vs. CAR-T Efficacy Comparison
Comparative analysis of efficacy, safety, and durability of response between bispecific antibodies and CAR-T cell therapies in relapsed/refractory multiple myeloma.
TYK2 Inhibitor Formulary Positioning
Analysis of payer coverage decisions and formulary positioning for TYK2 inhibitors in moderate-to-severe plaque psoriasis across commercial and Medicare plans.
ADC Development Pipeline Landscape
Comprehensive overview of antibody-drug conjugate (ADC) development pipeline in breast cancer, with focus on novel targets, payloads, and linker technologies.
Evolving Treatment Paradigm Perspectives
Summary of key opinion leader perspectives on the evolving treatment paradigm in psoriatic arthritis, with focus on JAK inhibitors and IL-23 antagonists.
MRD as Surrogate Endpoint Analysis
Analysis of regulatory acceptance of minimal residual disease (MRD) as a surrogate endpoint in multiple myeloma clinical trials and implications for development strategies.
Biologic Switching Patterns in Clinical Practice
Analysis of real-world biologic switching patterns in severe asthma patients, with focus on reasons for discontinuation and subsequent treatment choices.
© 2025 CI Agent. All rights reserved.